Matches in SemOpenAlex for { <https://semopenalex.org/work/W978011015> ?p ?o ?g. }
- W978011015 endingPage "126" @default.
- W978011015 startingPage "117" @default.
- W978011015 abstract "This chapter discusses the agents with activity primarily against RNA viruses. The communicable diseases of the respiratory tract are probably the most common cause of symptomatic human infections. The viruses that are causative agents for human respiratory disease comprise the five taxonomically distinct families: orthomyxoviridae, paramyxoviridae, picornaviridae, coronaviridae, and adenoviridae. The influenza viruses, which consist of types A, B, and C, belong to the family orthomyxoviridae. Types A and B have been associated with significant increases in mortality during epidemics. The disease may be asymptomatic or cause symptoms ranging from the common cold to fatal pneumonia. Immunization against influenza has been recommended for high-risk groups and antiviral chemotherapy (amantadine) is available for the treatment and prophylaxis of all influenza A infections. There is both a great need for and interest in developing a chemotherapeutic agent for the treatment of these two viral, respiratory tract pathogens. The family picornaviridae contains the genus Rhinovirus that is composed of over a hundred distinct serotypes. Amantadine and rimantadine are specifically active against influenza A virus infections. The amantadine recipients reported a higher incidence of side effects largely attributed to the central nervous system (CNS) symptoms. This difference in side effects may be a pharmacokinetic phenomenon that results in higher plasma concentrations of amantadine. Significant progress continues to be made in the clinical use and development of agents active against DNA viruses. Acyclovir (9-(2-h droxyethoxymethyl)guanine) has been the subject of several reviews and of a syrnposium. Considerable progress has been made in evaluating the clinical promise of acyclovir; however, there remains much to be learned concerning the best use of this drug in clinical practice. Significant strides have been made in the development of clinically useful antiviral agents, especially against the DNA viruses of the herpes family. Most of these agents are directed against viral nucleic acid synthesis and require activation by a virus-induced thymidine kinase. Researchers have begun to focus on other strategies that may produce broader spectrum anti-viral agents with different mechanisms of action." @default.
- W978011015 created "2016-06-24" @default.
- W978011015 creator A5085168724 @default.
- W978011015 date "1984-01-01" @default.
- W978011015 modified "2023-09-25" @default.
- W978011015 title "Chapter 12. Antiviral Agents" @default.
- W978011015 cites W1488506473 @default.
- W978011015 cites W1555762369 @default.
- W978011015 cites W193225809 @default.
- W978011015 cites W1963755435 @default.
- W978011015 cites W1965179416 @default.
- W978011015 cites W1968210320 @default.
- W978011015 cites W1968855143 @default.
- W978011015 cites W1968899052 @default.
- W978011015 cites W1970315269 @default.
- W978011015 cites W1974055185 @default.
- W978011015 cites W1975534052 @default.
- W978011015 cites W1976466959 @default.
- W978011015 cites W1978429761 @default.
- W978011015 cites W1979257607 @default.
- W978011015 cites W1982618646 @default.
- W978011015 cites W1982664618 @default.
- W978011015 cites W1983540655 @default.
- W978011015 cites W1988873593 @default.
- W978011015 cites W1989498164 @default.
- W978011015 cites W1992841135 @default.
- W978011015 cites W1994821644 @default.
- W978011015 cites W1997939883 @default.
- W978011015 cites W2000897207 @default.
- W978011015 cites W2002553384 @default.
- W978011015 cites W2002745614 @default.
- W978011015 cites W2004960318 @default.
- W978011015 cites W2007250859 @default.
- W978011015 cites W2013581671 @default.
- W978011015 cites W2013832175 @default.
- W978011015 cites W2017011996 @default.
- W978011015 cites W2018310524 @default.
- W978011015 cites W2020510969 @default.
- W978011015 cites W2023036301 @default.
- W978011015 cites W2023175947 @default.
- W978011015 cites W2027208025 @default.
- W978011015 cites W2028939028 @default.
- W978011015 cites W2035347778 @default.
- W978011015 cites W2037772617 @default.
- W978011015 cites W2038290546 @default.
- W978011015 cites W2041429740 @default.
- W978011015 cites W2044139415 @default.
- W978011015 cites W2046747639 @default.
- W978011015 cites W2048171540 @default.
- W978011015 cites W2048726074 @default.
- W978011015 cites W2051993766 @default.
- W978011015 cites W2055594999 @default.
- W978011015 cites W2063031518 @default.
- W978011015 cites W2065370343 @default.
- W978011015 cites W2068446033 @default.
- W978011015 cites W2072494909 @default.
- W978011015 cites W2077757866 @default.
- W978011015 cites W2079875087 @default.
- W978011015 cites W2090852262 @default.
- W978011015 cites W2091967985 @default.
- W978011015 cites W2093214578 @default.
- W978011015 cites W2110984213 @default.
- W978011015 cites W2112642045 @default.
- W978011015 cites W2117128141 @default.
- W978011015 cites W2122297292 @default.
- W978011015 cites W2123470711 @default.
- W978011015 cites W2136398951 @default.
- W978011015 cites W2147004704 @default.
- W978011015 cites W2166297772 @default.
- W978011015 cites W2168251119 @default.
- W978011015 cites W2170312298 @default.
- W978011015 cites W2172081998 @default.
- W978011015 cites W2252247516 @default.
- W978011015 cites W2314560722 @default.
- W978011015 cites W2314780663 @default.
- W978011015 cites W2315523527 @default.
- W978011015 cites W2319815586 @default.
- W978011015 cites W2320211017 @default.
- W978011015 cites W2330005789 @default.
- W978011015 cites W2334193689 @default.
- W978011015 cites W2336923384 @default.
- W978011015 cites W2339746191 @default.
- W978011015 cites W2406871145 @default.
- W978011015 cites W2413452243 @default.
- W978011015 cites W2418662665 @default.
- W978011015 cites W2422568870 @default.
- W978011015 cites W2436328871 @default.
- W978011015 cites W2442809004 @default.
- W978011015 cites W2996851391 @default.
- W978011015 cites W4238035754 @default.
- W978011015 cites W4239765142 @default.
- W978011015 cites W4240587972 @default.
- W978011015 cites W4241477134 @default.
- W978011015 cites W4251906739 @default.
- W978011015 cites W4290664334 @default.
- W978011015 cites W4291308972 @default.
- W978011015 cites W997036647 @default.
- W978011015 doi "https://doi.org/10.1016/s0065-7743(08)60688-0" @default.